Development of peritoneal macrophage along a dendritic cell lineage in response to uptake of oligomannose-coated liposomes

Cellular Immunology

Volumn 271, Issue 2, 2011, Pages 335-341

  Kojima, Naoya ^a   Kato, Chiaki ^a   Igarashi, Megumi ^a   Ishii, Mariko ^a  

^a TOKAI UNIVERSITY   (Japan)

Author keywords

Dendritic cells; Liposome; Oligomannose; Peritoneal macrophages

Indexed keywords

CD11B ANTIGEN; CD40 ANTIGEN; CD86 ANTIGEN; CHEMOKINE RECEPTOR CCR7; GLYCOPROTEIN P 15095; LIPOSOME; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MANNOSE OLIGOSACCHARIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ARTICLE; CELL DIFFERENTIATION; CELL LINEAGE; CELL TRANSPORT; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; IN VITRO STUDY; MATERIAL COATING; MOUSE; NONHUMAN; PERITONEAL CAVITY; PERITONEUM MACROPHAGE; PHENOTYPE; PRIORITY JOURNAL; SPLEEN;

ANIMALS; ANTIGENS, CD11B; ANTIGENS, CD11C; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL LINEAGE; DENDRITIC CELLS; FEMALE; LIPOSOMES; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED C57BL; OLIGOSACCHARIDES;

MUS;

EID: 80054047832     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2011.07.013     Document Type: Article

References (34)

1. Steinman R.M. The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 1991, 9:271-276.
2. Palucka K., Banchereau J. Dendritic cells: a link between innate and adaptive immunity. J. Clin. Immunol. 1999, 19:12-25.
3. Banchereau J., Steinman R.M. Dendritic cells and the control of immunity. Nature 1998, 392:245-252.
4. Pulendran B., Smith J.L., Caspary G., Brasel K., Pettit D., Maraskovsky E., Maliszewski C.R. Distinct dendritic cell subsets differentially regulate the class of immune response in vivo. Proc. Natl. Acad. Sci. USA 1996, 96:1036-1041.
5. Mayordomo J.I., Zorin T., Storkus W.J., Zitvogel L., Celluzzi C., Falo L.D., Melief C.J., Ildstad S.T., Kast W.M., Deleo A.B., Lotze M.T. Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity. Nat. Med. 1995, 1:1297-1302.
6. Fields R.C., Shimizu K., Mulé J.J. Murine dendritic cells pulsed with whole tumor lysates mediate potent antitumor immune responses in vitro and in vivo. Proc. Natl. Acad. Sci. USA 1998, 95:9482-9487.
7. Takagi H., Furuya N., Kojima N. Preferential production of IL-12 by peritoneal macrophages activated by liposomes prepared from neoglycolipids containing oligomannose residues. Cytokine 2007, 40:241-250.
8. Ikehara Y., Shiuchi N., Kabata-Ikehara S., Nakanishi H., Yokoyama N., Takagi H., Nagata T., Koide Y., Kuzushima K., Takahashi T., Tsujimura K., Kojima N. Effective induction of anti-tumor immune responses with oligomannose-coated liposome targeting to intraperitoneal macrophage. Cancer Lett. 2008, 260:137-145.
9. Shimizu Y., Takagi H., Nakayama T., Yamakami K., Tadakuma T., Yokoyama N., Kojima N. Intraperitoneal immunization with oligomannose-coated liposome-entrapped soluble leishmanial antigen induces antigen-specific T-helper type 1 immune response in BALB/c mice through uptake by peritoneal macrophages. Parasite Immunol. 2007, 29:229-239.
10. Kojima N., Biao L., Nakayama T., Ishii M., Ikehara Y., Tsujimura K. Oligomannose-coated liposomes as a therapeutic antigen-delivery and an adjuvant vehicle for induction of in vivo tumor immunity. J. Control. Release 2008, 129:26-32.
11. Nishikawa Y., Zhang H., Ikehara Y., Kojima N., Xuan X., Yokoyama N. Immunization of oligomannose-coated liposome-entrapped NcGRA7 protects dams and offspring from Neospora caninum infection in mice. Clin. Vaccine Immunol. 2009, 16:792-797.
12. Ishii M., Koyama A., Iseki H., Narumi H., Yokoyama N., Kojima N. Anti-allergic potential of oligomannose-coated liposome-entrapped Cry j 1 as immunotherapy for Japanese cedar pollinosis in mice. Int. Immunopharm. 2010, 10:1041-1046.
13. Trinchieri G. Proinflammatory and immunoregulatory functions of interleukin-12. Int. Rev. Immunol. 1998, 16:365-396.
14. Zhou L.J., Tedder T.F. CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells. Proc. Natl. Acad. Sci. USA 1996, 93:2588-2592.
15. Kiertscher S.M., Roth M.D. Human CD14+ leukocytes acquire the phenotype and function of antigen-presenting dendritic cells when cultured in GM-CSF and IL-4. J. Leukoc. Biol. 1996, 59:208-218.
16. Randolph G.J., Beaulie S., Lebecque S., Steinman R.M., Muller W.A. Differentiation of monocytes into dendritic cells in a model of transendothelial trafficking. Science 1998, 282:480-483.
17. Randolph G.J., Inaba K., Robbiani D.F., Steinman R.M., Muller W.A. Differentiation of phagocytic monocytes into lymph node dendritic cells in vivo. Immunity 1999, 11:753-761.
18. Rezzani R., Rodella L., Zauli G., Caimi L., Vitale M. Mouse peritoneal cells as a reservoir of late dendritic cell progenitors. Br. J. Haematol. 1999, 104:111-118.
19. Makala L.H., Nishikawa Y., Mishima M., Inoue N., Xuan X., Suzuki H., Fujisaki K., Mikami T., Nagasawa H. Phenotype and function of murine peritoneal cavity macrophage-derived dendritic cells. J. Vet. Med. Sci. 2002, 64:813-820.
20. McCully M.L., Chau T.A., Like P., Blake P.G., Madrenas J. Characterization of human peritoneal dendritic cell precursors and their involvement in peritonitis. Clin. Exp. Immunol. 2005, 139:513-525.
21. Ritter U., Wiede F., Mielenz D., Kiafard Z., Zwirner J., Körner H. Analysis of the CCR7 expression on murine bone marrow-derived and spleen dendritic cells. J. Leukoc. Biol. 2004, 76:472-476.
22. Ikehara Y., Niwa T., Biao L., Ikehara S., Ohashi N., Kobayashi T., Shimizu Y., Kojima N., Nakanishi H. A carbohydrate recognition based drug delivery and controlled release system using intraperitoneal macrophages as a cellular vehicle. Cancer Res. 2006, 66:8740-8748.
23. Ikehara Y., Development of a novel oligomannose-coated liposome-based anticancer drug delivery system for intraperitoneal cancer N.Kojima. Curr. Opin. Mol. Ther. 2007, 9:53-61.
24. Martin-Fontecha A., Sebastiani S., Höpken U.E., Uguccioni M., Lipp M., Lanzavecchia A., Sallusto F. Regulation of dendritic cell migration to the draining lymph node: impact on T lymphocyte traffic and priming. J. Exp. Med. 2003, 198:615-621.
25. Ohl L., Mohaupt M., Czeloth N., Hintzen G., Kiafard Z., Zwirner J., Blankenstein T., Henning G., Förster R. CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions. Immunity 2004, 21:279-288.
26. Geijtenbeek T.B., Torensma R., van Vliet S.J., van Duijnhoven G.C., Adema G.J., van Kooyk Y., Figdor C.G. Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses. Cell 2000, 100:575-585.
27. Appelmelk B.J., van Die I., van Vliet S.J., Vandenbroucke-Grauls C.M., Geijtenbeek T.B., van Kooyk Y. Cutting edge: carbohydrate profiling identifies new pathogens that interact with dendritic cell-specific ICAM-3-grabbing nonintegrin on dendritic cells. J. Immunol. 2003, 170:1635-1639.
28. Cambi A., Gijizen K., de Vries J.M., Torensma R., Joosten B., Adema G.J., Netea M.G., Kullberg B.J., Romani L., Figdor C.G. The C-type lectin DC-SIGN (CD209) is an antigen-uptake receptor for Candida albicans on dendritic cells. Eur. J. Immunol. 2003, 33:532-538.
29. Takahara K., Yashima Y., Omatsu Y., Yoshida H., Kimura Y., Kang Y.S., Steinman R.M., Park C.G., Inaba K. Functional comparison of the mouse DC-SIGN, SIGNR1, SIGNR3 and Langerin, C-type lectins. Int. Immunol. 2004, 16:819-829.
30. Abe Y., Kuroda Y., Kuboki N., Matsushita M., Yokoyama N., Kojima N. Contribution of complement component C3 and complement receptor type 3 to carbohydrate-dependent uptake of oligomannose-coated liposomes by peritoneal macrophages. J. Biochem. 2008, 144:563-570.
31. Takagi H., Numazaki M., Kajiwara T., Abe Y., Ishii M., Kato C., Kojima N. Cooperation of specific ICAM-3 grabbing nonintegrin related 1 (SIGNR1) and complement receptor type 3 (CR3) in uptake of oligomannose-coated liposomes by macrophages. Glycobiology 2009, 19:258-266.
32. Caux C., Vanbervliet B., Massacrier C., Dezutter-Dambuyant C., de Saint-Vis B., Jacquet C., Yoneda K., Imamura S., Schmitt D., Banchereau J. CD34(+) hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF alpha. J. Exp. Med. 1996, 184:695-706.
33. Kato C., Kajiwara T., Numazaki M., Takagi H., Kojima N. Oligomannose-coated liposomes activate ERK via Src kinases and PI3K/Akt in J774A.1 cells. Biochem. Biophys. Res. Commun. 2008, 372:898-901.
34. Numazaki M., Kato C., Kawauchi Y., Kajiwara T., Ishii M., Kojima N. Cross-linking of SIGNR1 activates JNK and induces TNF-α production in RAW264.7 cells that express SIGNR1. Biochem. Biophys. Res. Commun. 2009, 286:202-206.